0000950103-18-002747.txt : 20180301 0000950103-18-002747.hdr.sgml : 20180301 20180301122525 ACCESSION NUMBER: 0000950103-18-002747 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 5 CONFORMED PERIOD OF REPORT: 20180301 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20180301 DATE AS OF CHANGE: 20180301 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Shire plc CENTRAL INDEX KEY: 0000936402 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-37896 FILM NUMBER: 18655614 BUSINESS ADDRESS: STREET 1: BLOCK 2, MIESIAN PLAZA STREET 2: 50-58 BAGGOT STREET LOWER CITY: DUBLIN 2 STATE: L2 ZIP: D02 HW68 BUSINESS PHONE: 353-1-609-6000 MAIL ADDRESS: STREET 1: BLOCK 2, MIESIAN PLAZA STREET 2: 50-58 BAGGOT STREET LOWER CITY: DUBLIN 2 STATE: L2 ZIP: D02 HW68 FORMER COMPANY: FORMER CONFORMED NAME: Shire Ltd. DATE OF NAME CHANGE: 20080523 FORMER COMPANY: FORMER CONFORMED NAME: Shire plc DATE OF NAME CHANGE: 20051125 FORMER COMPANY: FORMER CONFORMED NAME: SHIRE PHARMACEUTICALS GROUP PLC DATE OF NAME CHANGE: 19980302 8-K 1 dp87567_8k.htm FORM 8-K

 


  
  
UNITED STATES  
SECURITIES AND EXCHANGE COMMISSION  
WASHINGTON, D.C. 20549
_____________________
 
FORM 8-K
 
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
 

 

Date of Report (Date of earliest event reported): March 1, 2018

 

SHIRE PLC
(Exact name of registrant as specified in its charter)

 

Jersey, Channel Islands 0-29630 98-0601486
(State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.)

 

Block 2

Miesian Plaza

50-58 Baggot Street Lower

Dublin 2

Republic of Ireland
(Address of principal executive offices)

   
Registrant’s telephone number, including area code:     +353 1 609 6000

 

(Former name or former address, if changed since last report)
 
______________________
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2.):
 

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

 

Emerging growth company ☐

 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 


 

 

 

Item 8.01. Other Events

 

Shire plc has issued the press releases attached hereto as Exhibits 99.1, 99.2 and 99.3 which are incorporated by reference herein.

 

Item 9.01. Financial Statements and Exhibits

 

(d) Exhibits. The following exhibits are filed herewith:

 

99.1       Press Release dated March 1, 2018

 

99.2       Press Release dated March 1, 2018

 

99.3       Press Release dated March 1, 2018

 

 

 

 

 

EXHIBIT INDEX

 

Exhibit No. 

 

Description 

   
99.1   Press Release dated March 1, 2018
     
99.2   Press Release dated March 1, 2018
     
99.3   Press Release dated March 1, 2018

 

 

 

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  Shire plc  
     
         
  By:  /s/ W R Mordan  
    Name: Bill Mordan  
    Title: Company Secretary  

 

Date: March 1, 2018

 

 

EX-99.1 2 dp87567_ex9901.htm EXHIBIT 99.1

Exhibit 99.1

 

 

Press Release SL_rgb_lo_blue_pms3005 release.jpg 
www.shire.com  

 

 

Director/PDMR Shareholding

 

March 1, 2018 – Shire plc (LSE: SHP, NASDAQ: SHPG) (the “Company”)

 

Notification of transactions by person discharging managerial responsibilities

 

1. Details of the person discharging managerial responsibilities (“PDMR”) / person closely associated them (“PCA”)
a) Name Perry Sternberg
2. Reason for the notification
a) Position / status Head of US Commercial - PDMR
b) Initial notification / amendment Initial notification
3. Details of the issuer, emission allowance participant, auction platform, auctioneer or auction monitor
a) Name Shire plc
b) LEI 54930005LQRLI2UXRQ59
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument

Shire plc American Depositary Shares (“ADSs”)

 

Identification code ISIN: US82481R1068
b) Nature of the transaction

Receipt of ADSs following the vesting of Restricted Stock Units (“RSUs”) awarded under the Shire Long Term Incentive Plan 2015 (“LTIP”) on February 26, 2016. In accordance with the rules of the LTIP, upon vesting the number of ADSs to be delivered was increased by an amount equivalent to the value of dividends paid by the Company in respect of the RSUs from the award date to the date of vesting.

 

(Details of related disposal of ADSs are referenced in section 5. below.)

c) Price(s) and volume(s) Price(s) Volume(s)
$0 219
d)

Aggregated information

- Aggregated volume

- Price 

N/A (single transaction)
e) Date of the transaction February 26, 2018
f) Place of the transaction N/A

 

 

5. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument

Shire plc American Depositary Shares (“ADSs”)

 

Identification code ISIN: US82481R1068
b) Nature of the transaction Automated disposal of ADSs in relation to the vesting of RSUs referenced in section 4. above. The proceeds of this disposal were used to satisfy personal tax liabilities arising from the vesting of the RSUs.
c) Price(s) and volume(s) Price(s) Volume(s)
$125.6108 82
d)

Aggregated information

- Aggregated volume 

- Price

N/A (single transaction)
e) Date of the transaction February 26, 2018
f) Place of the transaction NASDAQ
6. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument

Shire plc American Depositary Shares (“ADSs”)

 

Identification code ISIN: US82481R1068
b) Nature of the transaction

Receipt of ADSs following the vesting of Restricted Stock Units (“RSUs”) awarded under the Shire Long Term Incentive Plan 2015 (“LTIP”) on February 27, 2015. In accordance with the rules of the LTIP, upon vesting the number of ADSs to be delivered was increased by an amount equivalent to the value of dividends paid by the Company in respect of the RSUs from the award date to the date of vesting.

 

(Details of related disposal of ADSs are referenced in section 7. below.)

 

c) Price(s) and volume(s) Price(s) Volume(s)
$0 285
d)

Aggregated information

- Aggregated volume 

- Price

N/A (single transaction)
e) Date of the transaction February 27, 2018
f) Place of the transaction N/A

 

 

7. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument

Shire plc American Depositary Shares (“ADSs”)

 

Identification code ISIN: US82481R1068
b) Nature of the transaction Automated disposal of ADSs in relation to the vesting of RSUs referenced in section 6. above. The proceeds of this disposal were used to satisfy personal tax liabilities arising from the vesting of the RSUs.
c) Price(s) and volume(s) Price(s) Volume(s)
$125.2800 92
d)

Aggregated information

- Aggregated volume 

- Price

N/A (single transaction)
e) Date of the transaction February 27, 2018
f) Place of the transaction NASDAQ
8. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument

Shire plc American Depositary Shares (“ADSs”)

 

Identification code ISIN: US82481R1068
b) Nature of the transaction

Receipt of ADSs following the vesting of Performance Stock Units (“PSUs”) awarded under the Shire Long Term Incentive Plan 2015 (“LTIP”) on February 27, 2015. In accordance with:

 

(i) performance conditions measured over the period January 1, 2015, to December 31, 2017, 38% of the PSUs vested; and

 

(ii) the rules of the LTIP, upon vesting the number of ADSs to be delivered was increased by an amount equivalent to the value of dividends paid by the Company in respect of the PSUs from the award date to the date of vesting.

 

(Details of related disposal of ADSs are referenced in section 9. below.)

c) Price(s) and volume(s) Price(s) Volume(s)
$0 307
d)

Aggregated information

- Aggregated volume 

- Price

N/A (single transaction)
e) Date of the transaction February 27, 2018
f) Place of the transaction N/A

 

 

9. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument

Shire plc American Depositary Shares (“ADSs”)

 

Identification code ISIN: US82481R1068
b) Nature of the transaction Automated disposal of ADSs in relation to the vesting of PSUs referenced in section 8. above. The proceeds of this disposal were used to satisfy personal tax liabilities arising from the vesting of the PSUs.
c) Price(s) and volume(s) Price(s) Volume(s)
$125.2800 99
d)

Aggregated information

- Aggregated volume 

- Price

N/A (single transaction)
e) Date of the transaction February 27, 2018
f) Place of the transaction NASDAQ

 

 

 

1. Details of the person discharging managerial responsibilities (“PDMR”) / person closely associated them (“PCA”)
a) Name Kim Stratton
2. Reason for the notification
a) Position / status Head of International Commercial - PDMR
b) Initial notification / amendment Initial notification
3. Details of the issuer, emission allowance participant, auction platform, auctioneer or auction monitor
a) Name Shire plc
b) LEI 54930005LQRLI2UXRQ59
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument

Shire plc Ordinary Shares of 5 pence each (“Ordinary Shares”)

 

Identification code ISIN: JE00B2QKY057
b) Nature of the transaction

Receipt of Ordinary Shares following the vesting of Restricted Stock Units (“RSUs”) awarded under the Shire Long Term Incentive Plan 2015 (“LTIP”) on February 26, 2016. In accordance with the rules of the LTIP, upon vesting the number of Ordinary Shares to be delivered was increased by an amount equivalent to the value of dividends paid by the Company in respect of the RSUs from the award date to the date of vesting.

 

(Details of related disposal of Ordinary Shares are referenced in section 5. below.)

c) Price(s) and volume(s) Price(s) Volume(s)
£0 370
d)

Aggregated information

- Aggregated volume 

- Price

N/A (single transaction)
e) Date of the transaction February 26, 2018
f) Place of the transaction N/A

 

 

5. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument

Shire plc Ordinary Shares of 5 pence each (“Ordinary Shares”)

 

Identification code ISIN: JE00B2QKY057
b) Nature of the transaction Automated disposal of Ordinary Shares in relation to the vesting of RSUs referenced in section 4. above. The proceeds of this disposal were used to satisfy personal tax liabilities arising from the vesting of the RSUs.
c) Price(s) and volume(s) Price(s) Volume(s)
£29.9922 112
d)

Aggregated information

- Aggregated volume 

- Price

N/A (single transaction)
e) Date of the transaction February 26, 2018
f) Place of the transaction London Stock Exchange
6. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument

Shire plc Ordinary Shares of 5 pence each (“Ordinary Shares”)

 

Identification code ISIN: JE00B2QKY057
b) Nature of the transaction

Receipt of Ordinary Shares following the vesting of Restricted Stock Units (“RSUs”) awarded under the Shire Long Term Incentive Plan 2015 (“LTIP”) on February 27, 2015. In accordance with the rules of the LTIP, upon vesting the number of Ordinary Shares to be delivered was increased by an amount equivalent to the value of dividends paid by the Company in respect of the RSUs from the award date to the date of vesting.

 

(Details of related disposal of Ordinary Shares are referenced in section 7. below.)

c) Price(s) and volume(s) Price(s) Volume(s)
£0 607
d)

Aggregated information

- Aggregated volume 

- Price

N/A (single transaction)
e) Date of the transaction February 27, 2018
f) Place of the transaction N/A

 

 

7. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument

Shire plc Ordinary Shares of 5 pence each (“Ordinary Shares”)

 

Identification code ISIN: JE00B2QKY057
b) Nature of the transaction Automated disposal of Ordinary Shares in relation to the vesting of RSUs referenced in section 6. above. The proceeds of this disposal were used to satisfy personal tax liabilities arising from the vesting of the RSUs.
c) Price(s) and volume(s) Price(s) Volume(s)
£30.4151 183
d)

Aggregated information

- Aggregated volume

- Price 

N/A (single transaction)
e) Date of the transaction February 27, 2018
f) Place of the transaction London Stock Exchange
8. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument

Shire plc Ordinary Shares of 5 pence each (“Ordinary Shares”)

 

Identification code ISIN: JE00B2QKY057
b) Nature of the transaction

Receipt of Ordinary Shares following the vesting of Performance Stock Units (“PSUs”) awarded under the Shire Long Term Incentive Plan 2015 (“LTIP”) on February 27, 2015. In accordance with:

 

(i) performance conditions measured over the period January 1, 2015, to December 31, 2017, 38% of the PSUs vested; and

 

(ii) the rules of the LTIP, upon vesting the number of Ordinary Shares to be delivered was increased by an amount equivalent to the value of dividends paid by the Company in respect of the PSUs from the award date to the date of vesting.

 

(Details of related disposal of Ordinary Shares are referenced in section 9. below.)

c) Price(s) and volume(s) Price(s) Volume(s)
£0 659
d)

Aggregated information

- Aggregated volume 

- Price

N/A (single transaction)
e) Date of the transaction February 27, 2018
f) Place of the transaction N/A

 

 

9. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument

Shire plc Ordinary Shares of 5 pence each (“Ordinary Shares”)

 

Identification code ISIN: JE00B2QKY057
b) Nature of the transaction Automated disposal of Ordinary Shares in relation to the vesting of PSUs referenced in section 8. above. The proceeds of this disposal were used to satisfy personal tax liabilities arising from the vesting of the PSUs.
c) Price(s) and volume(s) Price(s) Volume(s)
£30.4151 199
d)

Aggregated information

- Aggregated volume 

- Price

N/A (single transaction)
e) Date of the transaction February 27, 2018
f) Place of the transaction London Stock Exchange

 

 

 

1. Details of the person discharging managerial responsibilities (“PDMR”) / person closely associated them (“PCA”)
a) Name Joanne Cordeiro
2. Reason for the notification
a) Position / status Chief Human Resources Officer - PDMR
b) Initial notification / amendment Initial notification
3. Details of the issuer, emission allowance participant, auction platform, auctioneer or auction monitor
a) Name Shire plc
b) LEI 54930005LQRLI2UXRQ59
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument

Shire plc American Depositary Shares (“ADSs”)

 

Identification code ISIN: US82481R1068
b) Nature of the transaction

Receipt of ADSs following the vesting of Restricted Stock Units (“RSUs”) awarded under the Shire Long Term Incentive Plan 2015 (“LTIP”) on February 26, 2016. In accordance with the rules of the LTIP, upon vesting the number of ADSs to be delivered was increased by an amount equivalent to the value of dividends paid by the Company in respect of the RSUs from the award date to the date of vesting.

 

(Details of related disposal of ADSs are referenced in section 5. below.)

c) Price(s) and volume(s) Price(s) Volume(s)
$0 85
d)

Aggregated information

- Aggregated volume 

- Price

N/A (single transaction)
e) Date of the transaction February 26, 2018
f) Place of the transaction N/A
5. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument

Shire plc American Depositary Shares (“ADSs”)

 

Identification code ISIN: US82481R1068
b) Nature of the transaction Automated disposal of ADSs in relation to the vesting of RSUs referenced in section 4. above. The proceeds of this disposal were used to satisfy personal tax liabilities arising from the vesting of the RSUs.
c) Price(s) and volume(s) Price(s) Volume(s)
$125.6108 33
d)

Aggregated information

- Aggregated volume 

- Price

N/A (single transaction)
e) Date of the transaction February 26, 2018
f) Place of the transaction NASDAQ

 

 

6. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument

Shire plc American Depositary Shares (“ADSs”)

 

Identification code ISIN: US82481R1068
b) Nature of the transaction

Receipt of ADSs following the vesting of Restricted Stock Units (“RSUs”) awarded under the Shire Long Term Incentive Plan 2015 (“LTIP”) on February 27, 2015. In accordance with the rules of the LTIP, upon vesting the number of ADSs to be delivered was increased by an amount equivalent to the value of dividends paid by the Company in respect of the RSUs from the award date to the date of vesting.

 

(Details of related disposal of ADSs are referenced in section 7. below.)

c) Price(s) and volume(s) Price(s) Volume(s)
$0 93
d)

Aggregated information

- Aggregated volume 

- Price

N/A (single transaction)
e) Date of the transaction February 27, 2018
f) Place of the transaction N/A
7. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument

Shire plc American Depositary Shares (“ADSs”)

 

Identification code ISIN: US82481R1068
b) Nature of the transaction Automated disposal of ADSs in relation to the vesting of RSUs referenced in section 6. above. The proceeds of this disposal were used to satisfy personal tax liabilities arising from the vesting of the RSUs.
c) Price(s) and volume(s) Price(s) Volume(s)
$125.2800 36
d)

Aggregated information

- Aggregated volume 

- Price

N/A (single transaction)
e) Date of the transaction February 27, 2018
f) Place of the transaction NASDAQ

 

 

8. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument

Shire plc American Depositary Shares (“ADSs”)

 

Identification code ISIN: US82481R1068
b) Nature of the transaction

Receipt of ADSs following the vesting of Performance Stock Units (“PSUs”) awarded under the Shire Long Term Incentive Plan 2015 (“LTIP”) on February 27, 2015. In accordance with:

 

(i) performance conditions measured over the period January 1, 2015, to December 31, 2017, 38% of the PSUs vested; and

 

(ii) the rules of the LTIP, upon vesting the number of ADSs to be delivered was increased by an amount equivalent to the value of dividends paid by the Company in respect of the PSUs from the award date to the date of vesting.

 

(Details of related disposal of ADSs are referenced in section 9. below.)

c) Price(s) and volume(s) Price(s) Volume(s)
$0 100
d)

Aggregated information

- Aggregated volume 

- Price

N/A (single transaction)
e) Date of the transaction February 27, 2018
f) Place of the transaction N/A
9. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument

Shire plc American Depositary Shares (“ADSs”)

 

Identification code ISIN: US82481R1068
b) Nature of the transaction Automated disposal of ADSs in relation to the vesting of PSUs referenced in section 8. above. The proceeds of this disposal were used to satisfy personal tax liabilities arising from the vesting of the PSUs.
c) Price(s) and volume(s) Price(s) Volume(s)
$125.2800 39
d)

Aggregated information

- Aggregated volume 

- Price

N/A (single transaction)
e) Date of the transaction February 27, 2018
f) Place of the transaction NASDAQ

 

 

10. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument

Shire plc American Depositary Shares (“ADSs”)

 

Identification code ISIN: US82481R1068
b) Nature of the transaction

Receipt of ADSs following the vesting of Restricted Stock Units (“RSUs”) awarded under the Shire Long Term Incentive Plan 2015 (“LTIP”) on February 28, 2017. In accordance with the rules of the LTIP, upon vesting the number of ADSs to be delivered was increased by an amount equivalent to the value of dividends paid by the Company in respect of the RSUs from the award date to the date of vesting.

 

(Details of related disposal of ADSs are referenced in section 11. below.)

c) Price(s) and volume(s) Price(s) Volume(s)
$0 103
d)

Aggregated information

- Aggregated volume

- Price

N/A (single transaction)
e) Date of the transaction February 28, 2018
f) Place of the transaction N/A
11. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument

Shire plc American Depositary Shares (“ADSs”)

 

Identification code ISIN: US82481R1068
b) Nature of the transaction Automated disposal of ADSs in relation to the vesting of RSUs referenced in section 10. above. The proceeds of this disposal were used to satisfy personal tax liabilities arising from the vesting of the RSUs.
c) Price(s) and volume(s) Price(s) Volume(s)
$128.6176 35
d)

Aggregated information

- Aggregated volume 

- Price

N/A (single transaction)
e) Date of the transaction February 28, 2018
f) Place of the transaction NASDAQ

 

 

12. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument

Shire plc American Depositary Shares (“ADSs”)

 

Identification code ISIN: US82481R1068
b) Nature of the transaction Acquisition of ADSs following the automatic re-investment of dividends received, as paid to shareholders on October 20, 2017.
c) Price(s) and volume(s) Price(s) Volume(s)
$145.7400 0.1992
d)

Aggregated information

- Aggregated volume 

- Price

N/A (single transaction)
e) Date of the transaction October 20, 2017
f) Place of the transaction NASDAQ

 

Oliver Strawbridge

Senior Assistant Company Secretary

 

For further information please contact:

 

Investor Relations    
Christoph Brackmann christoph.brackmann@shire.com +41 795 432 359
Robert Coates rcoates@shire.com +44 203 549 0874
Sun Kim sun.kim@shire.com +1 617 588 8175
Media    
Katie Joyce kjoyce@shire.com   +1 781 482 2779

 

NOTES TO EDITORS

 

About Shire

 

Shire is the global leader in serving patients with rare diseases. We strive to develop best-in-class therapies across a core of rare disease areas including hematology, immunology, genetic diseases, neuroscience, and internal medicine with growing therapeutic areas in ophthalmics and oncology. Our diversified capabilities enable us to reach patients in more than 100 countries who are struggling to live their lives to the fullest.

 

We feel a strong sense of urgency to address unmet medical needs and work tirelessly to improve people’s lives with medicines that have a meaningful impact on patients and all who support them on their journey.

 

www.shire.com

 

 

 

EX-99.2 3 dp87567_ex9902.htm EXHIBIT 99.2

Exhibit 99.2

 

 

Press Release SL_rgb_lo_blue_pms3005 release.jpg 
www.shire.com  

 

 

Director/PDMR Shareholding

 

March 1, 2018 – Shire plc (LSE: SHP, NASDAQ: SHPG)

 

Notification of transactions by person discharging managerial responsibilities

 

1. Details of the person discharging managerial responsibilities (“PDMR”) / person closely associated them (“PCA”)
a) Name Albert Stroucken / Gerda Stroucken
2. Reason for the notification
a) Position / status Non-Executive Director (PDMR) / PCA of Albert Stroucken
b) Initial notification / amendment Initial notification
3. Details of the issuer, emission allowance participant, auction platform, auctioneer or auction monitor
a) Name Shire plc
b) LEI 54930005LQRLI2UXRQ59
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument

Shire plc American Depositary Shares (“ADSs”)

 

Identification code ISIN: US82481R1068
b) Nature of the transaction Acquisition, by PDMR and PCA, of beneficial interest in ADSs by virtue of transfer from grantor retained annuity trust (“GRAT”). Mr. Stroucken is the sole trustee of the GRAT.
c) Price(s) and volume(s) Price(s) Volume(s)
$0 9,437
d)

Aggregated information

- Aggregated volume 

- Price

N/A (single transaction)
e) Date of the transaction February 28, 2018
f) Place of the transaction N/A

 

Oliver Strawbridge

Senior Assistant Company Secretary

 

 

 

For further information please contact:

 

Investor Relations    
Christoph Brackmann christoph.brackmann@shire.com +41 795 432 359
Robert Coates rcoates@shire.com +44 203 549 0874
Sun Kim sun.kim@shire.com +1 617 588 8175
Media    
Katie Joyce kjoyce@shire.com   +1 781 482 2779

 

NOTES TO EDITORS

 

About Shire

 

Shire is the global leader in serving patients with rare diseases. We strive to develop best-in-class therapies across a core of rare disease areas including hematology, immunology, genetic diseases, neuroscience, and internal medicine with growing therapeutic areas in ophthalmics and oncology. Our diversified capabilities enable us to reach patients in more than 100 countries who are struggling to live their lives to the fullest.

 

We feel a strong sense of urgency to address unmet medical needs and work tirelessly to improve people’s lives with medicines that have a meaningful impact on patients and all who support them on their journey.

 

www.shire.com 

 

 

 

 

EX-99.3 4 dp87567_ex9903.htm EXHIBIT 99.3

Exhibit 99.3

 

 

Press Release SL_rgb_lo_blue_pms3005 release.jpg 
www.shire.com  

 

 

Total Voting Rights

 

March 1, 2018 - Shire plc (LSE: SHP, NASDAQ: SHPG) (the “Company”), in accordance with 5.6.1R of the Financial Conduct Authority's (the “FCA”) Disclosure Guidance and Transparency Rules, notifies the market of the following:

 

As at February 28, 2018, the Company’s issued ordinary share capital comprised 910,730,768 ordinary shares of 5 pence each with voting rights and a further 7,357,283 ordinary shares held in treasury.

 

Therefore, the total number of voting rights in the Company is 910,730,768. This is the figure which should be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

Sarah Rixon

Company Secretarial Assistant

 

 

 

For further information please contact:

 

Investor Relations    
Christoph Brackmann christoph.brackmann@shire.com +41 795 432 359
Robert Coates rcoates@shire.com +44 203 549 0874
Sun Kim sun.kim@shire.com +1 617 588 8175
Media    
Katie Joyce kjoyce@shire.com   +1 781 482 2779

 

 

NOTES TO EDITORS

 

About Shire

 

Shire is the global leader in serving patients with rare diseases. We strive to develop best-in-class therapies across a core of rare disease areas including hematology, immunology, genetic diseases, neuroscience, and internal medicine with growing therapeutic areas in ophthalmics and oncology. Our diversified capabilities enable us to reach patients in more than 100 countries who are struggling to live their lives to the fullest.

 

We feel a strong sense of urgency to address unmet medical needs and work tirelessly to improve people’s lives with medicines that have a meaningful impact on patients and all who support them on their journey.

 

www.shire.com

 

 

 

 

 

Registered in Jersey, No. 99854, 22 Grenville Street, St Helier, Jersey JE4 8PX

 

 

 

GRAPHIC 5 image_001.jpg GRAPHIC begin 644 image_001.jpg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end